Search

Intuitive Surgical Inc

Open

SectorHealthcare

371.66 -0.47

Overview

Share price change

24h

Current

Min

366.93

Max

377.59

Key metrics

By Trading Economics

Income

1.7M

823M

Sales

122M

2.9B

P/E

Sector Avg

45.229

57.371

EPS

2.8

Profit margin

28.462

Employees

17,021

EBITDA

34M

1.2B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+30.81% upside

Dividends

By Acuity

Next Earnings

20 paź 2026

Market Stats

By TradingEconomics

Market Cap

-4.2B

140B

Previous open

372.13

Previous close

371.66

News Sentiment

By Acuity

21%

79%

56 / 340 Ranking in Healthcare

Intuitive Surgical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 sie 2026, 19:16 UTC

News

Intuitive Surgical reported second-quarter earnings of $2.80 per share, exceeding expectations, but shares are lower since Friday's close amid broader market concerns.

21 sie 2026, 19:46 UTC

News

Intuitive Surgical reports strong Q2 results with revenue up 18.5%. Shares are higher, reflecting solid guidance and a significant acquisition by Bank of New York Mellon.

20 sie 2026, 19:51 UTC

Intuitive Surgical Inc shares are lower today, breaking a trend of higher closes. No specific news was identified to explain the decline.

19 sie 2026, 19:26 UTC

News
Correlated Moves

Intuitive Surgical shares reached a four-week high of $404.99, trading higher during Wednesday's session, despite earlier pulling back from a session peak.

18 sie 2026, 23:21 UTC

Intuitive Surgical Inc's shares are higher in after-hours trading, despite a lack of specific news. The stock remains above its 20-day moving average.

17 sie 2026, 23:16 UTC

Intuitive Surgical Inc. shares showed routine trading after-market hours, remaining roughly flat since Monday's close and positioned above its 20-day moving average.

13 sie 2026, 19:46 UTC

Correlated Moves

Intuitive Surgical shares are lower amid rising jobless claims, reflecting cautious market sentiment. The decline aligns with similar trends in Stryker Corp.

12 sie 2026, 19:56 UTC

News
Correlated Moves
Social Media

Intuitive Surgical Inc's shares are lower today, despite Oppenheimer upgrading the stock to Outperform with a $500 price target. Concerns about competition persist.

10 sie 2026, 20:02 UTC

News

Intuitive Surgical Inc. shares are higher, supported by gains in the Health Care Equipment sector, despite competitive pressures and growth guidance challenges.

7 sie 2026, 23:52 UTC

Intuitive Surgical Inc. shares traded lower in after-market hours, maintaining a position within their one-month range and above the 20-day moving average.

6 sie 2026, 19:36 UTC

Intuitive Surgical Inc's shares are lower today, with no specific news driving the decline. The stock remains within its one-month trading range.

5 sie 2026, 19:52 UTC

Intuitive Surgical Inc shares are higher today amid cautious market sentiment following ADP's report of weaker-than-expected private sector job growth.

4 sie 2026, 20:04 UTC

Correlated Moves

Intuitive Surgical Inc shares declined during Tuesday's session, continuing a downward trend seen in the health care equipment sector amid broader market pressures.

3 sie 2026, 20:03 UTC

Correlated Moves
News

Intuitive Surgical Inc shares are higher as the company reports a 19% revenue increase to $2.89 billion and reaffirms full-year guidance.

31 lip 2026, 23:41 UTC

Intuitive Surgical shares are higher in after-market hours, despite a broader market decline and trading near the lower end of its one-month range.

30 lip 2026, 20:09 UTC

Intuitive Surgical Inc. shares are near unchanged amid broader market volatility and disappointing economic data, including lower-than-expected GDP growth and rising jobless claims.

29 lip 2026, 23:21 UTC

Intuitive Surgical Inc. shares declined in after-market trading, reflecting ongoing weakness and a lack of momentum following an initial peak.

28 lip 2026, 18:32 UTC

News
Correlated Moves
Social Media

Intuitive Surgical Inc shares rose after UBS initiated coverage with a Buy rating and a $500 price target, reflecting confidence in growth potential.

27 lip 2026, 20:02 UTC

Social Media
News

Intuitive Surgical partners with Deion Sanders to boost awareness of robotic surgery options. Shares are trading higher amid positive market sentiment.

24 lip 2026, 17:02 UTC

Social Media
Correlated Moves
News

Intuitive Surgical shares are advancing as The Motley Fool identifies the company as a strong buy, citing solid medium-term prospects despite competitive challenges.

23 lip 2026, 20:03 UTC

News

Intuitive Surgical shares are lower today after a significant early drop, continuing a trend of three consecutive daily declines despite an AI-focused presentation at a conference.

22 lip 2026, 18:52 UTC

News

Intuitive Surgical shares lower as Johnson & Johnson gains FDA authorization for its Ottava Surgical Robot, raising competitive concerns in robotic surgery.

21 lip 2026, 19:42 UTC

News

Intuitive Surgical Inc shares are lower as analysts express caution amid rising GLP-1 medication use and the expiration of ACA enhanced premiums.

20 lip 2026, 19:41 UTC

Social Media
News

Intuitive Surgical's price target lowered to $685 by Bernstein, yet shares are higher today amid a recovery and new extended use program launch.

17 lip 2026, 19:41 UTC

News
Social Media

Intuitive Surgical shares are lower after analysts cut price targets, with Mizuho lowering its target to $400 amid concerns over slowing procedure trends.

16 lip 2026, 23:02 UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

15 lip 2026, 19:52 UTC

News

Intuitive Surgical reports first-quarter revenue of $2.77 billion, up from $2.25 billion last year. Shares are advancing despite a recent product recall.

14 lip 2026, 20:02 UTC

Correlated Moves
News

Intuitive Surgical shares are lower as Baird cuts price target to $525 from $610. The stock has reached a 25-month low at $395.02.

13 lip 2026, 23:11 UTC

Intuitive Surgical shares traded roughly flat in after-hours trading, showing little momentum amid broader market pressure on major tech stocks.

10 lip 2026, 20:06 UTC

Event

Intuitive Surgical Inc shares are lower as investors await Q2 earnings, with analysts estimating EPS of $2.41 and revenue of $2.8 billion.

Peer Comparison

Price change

Intuitive Surgical Inc Forecast

Price Target

By TipRanks

30.81% upside

12 Months Forecast

Average 488.68 USD  30.81%

High 685 USD

Low 366 USD

Based on 24 Wall Street analysts offering 12 month price targets forIntuitive Surgical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

24 ratings

20

Buy

3

Hold

1

Sell

Sentiment

By Acuity

56 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat